Food
Mediterranean Diet for Longevity
Mediterranean diet trials support fewer cardiovascular events and, in pooled evidence, fewer deaths among adults at cardiovascular risk.
The Mediterranean diet has become shorthand for eating well for a long life. Olive oil, vegetables, fish and a glass of wine at a long table: it may be the only eating plan that doubles as a travel poster. For Humanic Blue, the useful question is what the research actually measured when it studied this pattern and longevity.
Mostly, it measured cardiovascular disease. Three widely cited trials assigned people to different eating programs and found fewer combined heart and blood-vessel problems with Mediterranean-style programs. The people studied, comparison diets and outcomes differed. A 2023 analysis comparing dietary-program trials also found moderately certain evidence of fewer deaths from any cause among adults at increased cardiovascular risk. Cohort studies across broader populations link closer adherence with lower mortality, but they cannot prove the diet caused the difference. None of this establishes a maximum-lifespan effect, and one major trial was partly funded by olive-oil organizations.
Key Takeaways
- Mediterranean-style programs reduced combined heart and blood-vessel outcomes in trials involving people at high risk or with established disease. The programs and comparison diets differed.
- An analysis comparing randomized dietary-program trials found fewer deaths from any cause in adults at increased cardiovascular risk. The researchers rated the evidence moderately certain; it does not establish an effect on maximum lifespan.
- Across 54 cohort studies, closer adherence to a Mediterranean pattern was associated with fewer deaths from any cause. The pooled estimate was 4% lower risk per score point, a measure of adherence under the score used in each study rather than one universal serving of food. This association does not prove cause and effect.
- Wine is not required to follow the food pattern, and current CDC guidance says people who do not drink should not start.
What goes on the Mediterranean plate?
Harvard’s Nutrition Source describes a mainly plant-based pattern built around whole grains, olive oil, fruits, vegetables, beans, nuts, herbs and spices. Fish and seafood are the preferred animal proteins. Poultry, eggs and dairy appear in smaller amounts, with red meat limited.
It’s a pattern, not a menu. Nobody hands you a laminated meal plan. That flexibility is part of its appeal, and part of why studies of it are hard to compare.
What did three heart trials find?
Researchers have tested the diet against other diets in three widely cited randomized trials:
- Lyon, France. A team at the University Hospital of Saint-Étienne assigned survivors of a first heart attack to a Mediterranean-style program or a comparison diet. Over about four years, the Mediterranean group had fewer cardiac deaths or nonfatal heart attacks. The effect was unusually large, and the study counted those outcomes together rather than measuring lifespan.
- PREDIMED, Spain. The PREDIMED network studied adults aged 55 to 80 at high cardiovascular risk but without cardiovascular disease. It compared a Mediterranean diet with extra-virgin olive oil, one with mixed nuts, and advice to reduce fat. Over about five years, the combined rate of heart attack, stroke or cardiovascular death was about 31% and 28% lower in the Mediterranean groups. The first report was withdrawn and republished after problems with how some people were assigned to groups. Excluding those assignments produced similar results.
- CORDIOPREV, Spain. Researchers at Reina Sofía University Hospital compared Mediterranean and low-fat diets in adults with coronary heart disease. Over seven years, the Mediterranean group had a roughly 25% to 28% lower rate of the combined cardiovascular outcome. The trial was conducted at one center and most participants were men. The result among women was too uncertain to establish a difference. Olive-oil organizations were among its funders.
The trials point in the same direction, but they did not test identical programs. They studied different people, comparison diets, food support and combinations of outcomes. A separate analysis comparing randomized dietary-program trials found fewer deaths from any cause with Mediterranean programs than with minimal intervention in adults at increased cardiovascular risk. Those programs could also include medication, exercise and behavioral support. The finding supports fewer premature deaths during follow-up; it cannot isolate the food pattern’s contribution or establish an effect on maximum human lifespan. How each trial worked
Lower death rates in long studies
Trials last years; observational studies can follow people for decades. In the US Women’s Health Study, researchers scored the diets of initially healthy women and followed them for about 25 years. In a basic adjusted model, the highest adherence group had 23% lower mortality than the lowest. After further adjustment for lifestyle factors, the estimate narrowed to 11% lower, showing how much the model matters. A 2026 review of 54 studies that followed people’s eating habits over time found a 4% lower mortality risk per one-point increase on Mediterranean-diet adherence scores; the authors rated the evidence moderate certainty. A point represents closer matching to a pattern under a study’s scoring rules. The review allowed different validated scores, so a point is not one universal food serving or a personal dose.
That’s a link, not proof. People who eat this way may differ in other ways, too. The study details
How does the mortality evidence differ from the heart-event evidence in the diet trials?
What about the wine?
Some traditional descriptions include wine with meals. Current CDC guidance says people who do not drink should not start, even moderate drinking may carry health risks, and drinking less or not at all lowers risk. The landmark diet trials did not randomly isolate wine from the rest of the pattern, so they cannot show that wine was necessary for benefit.
Who does the research describe?
Most trial volunteers lived in Spain or France. CORDIOPREV’s were mostly men in their late 50s, and its effect showed up more clearly in men. The Women’s Health Study was about 95% white. The US data suggest the link travels, but anyone outside those groups is reading averages drawn from people who may not look much like them.
Which features of the trial populations matter when interpreting a Mediterranean-diet claim?
What’s Interesting
The Mediterranean diet’s evidence ran in an unusual order. It started with observations of Mediterranean populations with low rates of chronic disease, then gathered randomized trials over three decades, from Lyon in the 1990s to CORDIOPREV in 2022.
Plenty of diets start with a book deal and go looking for evidence afterward. This one ran the other way: people were eating it for generations before anyone thought to test it in a trial. The trials came late to a dinner that had been going on for a while.
What This Means in Practice
For living longer and better, the trial findings concern people at cardiovascular risk, and the observational studies cover broader groups. That distinction matters when discussing the pattern with a healthcare professional.
- Harvard’s Nutrition Source describes the food pattern: vegetables, legumes, whole grains and olive oil form its daily foundations, with fish and seafood preferred over red meat. This describes the pattern rather than establishing a personal meal or portion plan.
- CDC guidance addresses the wine question: people who do not drink should not start for a possible health benefit.
- The heart trials describe specific clinical situations: two of the three studied people with existing heart disease. A cardiologist can explain how those findings relate to care after a heart event.
A registered dietitian can adapt the pattern to your food traditions and budget.
Bottom Line
The Mediterranean diet’s randomized-trial evidence comes from cardiovascular-risk populations. Trials found fewer combined heart and blood-vessel events, and an analysis comparing randomized dietary programs found fewer deaths from any cause than with minimal intervention. Cohorts across broader populations also associate closer adherence with lower mortality, but differences between people other than diet may partly explain that association. These findings support fewer premature deaths during follow-up, not a claim about maximum human lifespan. The useful takeaway is the food pattern; wine is not required and does not fit current advice for people who do not already drink.
A NOTE FROM LONGEVITY365
We read research, consult expert perspectives and work to make complicated health information easier to understand. What you’re reading here reflects how we’ve interpreted and organized that information. It is educational content—not personal medical advice, diagnosis or treatment guidance.
We’re not perfect, and neither is the available research. Evidence changes, new studies emerge and what’s appropriate for one person may not be appropriate for another.
Use this article as a starting point for your own research and conversations with qualified professionals. Always talk with your doctor or another trusted healthcare professional before making decisions that could affect your health, particularly if you take medications, are receiving treatment, have existing health conditions, are pregnant or have other circumstances that could affect what’s appropriate for you.
Reader Questions
A few questions to carry into the comments or your next conversation. Please leave out identifying or personal medical details.
- 01Which part of this food question feels most practical in real life: what to eat, how much, timing, cost, or consistency?
- 02Where do you still see a gap between population evidence and the way one person actually eats?
- 03What would make "Mediterranean Diet for Longevity" easier to discuss without turning food into another thing to optimize perfectly?
Extra Insights & Sources
For readers who want the details behind each claim above.
What We Know
- A Mediterranean-style diet reduced heart events in randomized trials in both high-risk people and people with heart disease. Supported.
- Mediterranean dietary programs reduced all-cause mortality versus minimal intervention in a randomized-trial network meta-analysis of adults at increased cardiovascular risk. Supported, moderate certainty.
- Higher adherence is associated with lower all-cause mortality in large cohorts. Supported (observational).
- The diet emphasizes plants, legumes, whole grains, olive oil, nuts and fish, with little red meat. Established (definition).
What We Don’t Know
- Whether the pattern changes maximum human lifespan, or produces the same effects in populations unlike those studied. Unknown.
- How much of the benefit comes from olive oil or nuts specifically, rather than the whole pattern. Uncertain.
- Whether moderate wine adds anything, or subtracts. Contested.
The heart trials in detail
A composite endpoint counts several outcomes together. In the statistics below, risk ratios (RR), hazard ratios and odds ratios (OR) compare groups in different ways; values below 1 favor the Mediterranean program. A 95% confidence interval (CI) shows statistical uncertainty. RCT means randomized controlled trial, in which participants are assigned to comparison groups.
Lyon Diet Heart Study (1990s). The Lyon Diet Heart Study randomized 605 survivors of a first heart attack to a Mediterranean-type program or a prudent Western comparison diet. Over a mean of 46 months, cardiac death or nonfatal heart attack occurred 14 times in the Mediterranean group and 44 times in the control group. Adjusted risk ratios across three progressively broader composite outcomes ranged from 0.28 to 0.53. The unusually large effect, combined outcomes and older setting matter when applying the result today. These were survivors of a heart attack: the study tested prevention of further events, sometimes called secondary prevention.
PREDIMED (republished 2018). PREDIMED assigned 7,447 Spanish adults aged 55 to 80 at high cardiovascular risk, but without cardiovascular disease at enrollment, to a Mediterranean diet with extra-virgin olive oil, a Mediterranean diet with nuts, or advice to reduce dietary fat. During a median 4.8 years, the primary composite occurred in 96, 83 and 109 participants, respectively. Adjusted hazard ratios were 0.69 and 0.72. The original 2013 report was withdrawn and republished in 2018 after investigators found that some household members had entered without random assignment and some centers had not followed group-assignment rules. Results were similar after excluding 1,588 participants with known or suspected assignment problems. But the corrected analysis could not treat all assignments as if they had been made entirely by chance. More detail is in What Should I Eat to Live Longer?
CORDIOPREV (2022). The CORDIOPREV trial at Reina Sofía University Hospital in Córdoba randomized 1,002 adults with established coronary heart disease to a Mediterranean or low-fat program for seven years. Participants averaged 59.5 years of age, and 82.5% were men. The composite endpoint occurred in 87 people in the Mediterranean group and 111 in the low-fat group; adjusted hazard ratios ranged from 0.719 to 0.753. The prespecified sex result was significant among men but not among the 175 women, so the female estimate was imprecise rather than proof of no effect. The single-center trial received support from two olive-oil organizations as well as Spanish government and European Union sources.
Randomized-program synthesis (2023). A network meta-analysis included 40 trials and 35,548 adults at increased cardiovascular risk, with 12 trials classified as Mediterranean dietary programs. Compared with minimal intervention, Mediterranean programs reduced all-cause mortality (odds ratio 0.72, 95% CI 0.56 to 0.92), cardiovascular mortality, stroke and nonfatal heart attack; certainty was rated moderate. The estimated all-cause mortality difference for an intermediate-risk population was 17 fewer deaths per 1,000 over five years. The programs varied and could include medication, exercise and behavioral support, so this is evidence for whole programs, not a clean estimate for one food or one fixed menu.
| Question | Key evidence | Result | Label |
|---|---|---|---|
| Fewer heart events in high-risk people? | PREDIMED (RCT) | About 30% fewer | Supported |
| Fewer repeat heart events after heart disease? | Lyon, CORDIOPREV (RCTs) | Yes, in both | Supported |
| Fewer deaths from any cause? | Network meta-analysis of randomized programs | OR 0.72 vs. minimal intervention in higher-risk adults | Supported, moderate certainty |
| Lower mortality in broader populations? | 54 cohort studies | RR 0.96 per adherence-score point | Supported association; not causal proof |
| Maximum lifespan? | No direct evidence | Not established | Unknown |
The long-term studies in detail
Women’s Health Study (2024). In the Women’s Health Study, researchers scored the diets of 25,315 initially healthy US women, whose average age was 54.6, and followed them for a mean 24.7 years; 3,879 died. The highest adherence group had a hazard ratio of 0.77 in the basic model and 0.89 after additional adjustment for lifestyle factors. The cohort was 94.9% White, diet was self-reported at baseline and the observational design leaves residual confounding possible. The mediation analyses were exploratory explanations of an association, not proof of biological pathways.
Updated cohort meta-analysis (2026). A systematic review and meta-analysis for the Italian national Mediterranean-diet guideline included 54 cohort studies, 1,833,267 adults and 346,034 deaths, with two to 60 years of follow-up. Each one-point increase in a validated Mediterranean-diet score was associated with 4% lower all-cause mortality (RR 0.96, 95% CI 0.95 to 0.97). Higher scores indicate closer adherence under each score’s rules. The review accepted any validated score; it does not supply one universal food amount corresponding to a point. The authors rated certainty moderate. Cohort consistency strengthens an association but does not remove confounding or turn an adherence score into a single standardized diet.
Source Materials
- Harvard T.H. Chan School of Public Health, The Nutrition Source. Describes the Mediterranean pattern’s plant foods, olive oil, fish and smaller amounts of other animal foods. This is an academic explainer and definition, not a clinical-outcomes trial. Mediterranean Diet
- de Lorgeril et al., Lyon Diet Heart Study, Circulation (PMIDs 9049571 and 9989963). The methods report documents randomization of 605 survivors of a first heart attack; the final report gives a mean 46-month follow-up, 14 versus 44 cardiac-death/nonfatal-heart-attack events and broader composite risk ratios. Its population had already survived a heart attack, the care setting is older and the unusually large effects concern combined outcomes. These features limit generalization. https://pubmed.ncbi.nlm.nih.gov/9049571/ https://pubmed.ncbi.nlm.nih.gov/9989963/
- Estruch et al., corrected PREDIMED report, New England Journal of Medicine (PMID 29897866). Assigned 7,447 Spanish adults aged 55–80 at high cardiovascular risk and followed them for a median 4.8 years. Supports event counts and adjusted hazard ratios. The authors withdrew the 2013 report and issued this corrected analysis after failures to follow group-assignment rules; results were similar after excluding 1,588 potentially affected participants. https://pubmed.ncbi.nlm.nih.gov/29897866/
- Delgado-Lista et al., CORDIOPREV, The Lancet (PMID 35525255). Seven-year, single-center randomized trial in 1,002 adults with coronary heart disease. Supports the 87 versus 111 composite events and adjusted hazard ratios; 82.5% of participants were men, and two olive-oil organizations were among the funders. https://pubmed.ncbi.nlm.nih.gov/35525255/
- Karam et al., BMJ (PMID 36990505). Network meta-analysis of 40 randomized trials and 35,548 adults at increased cardiovascular risk, including 12 Mediterranean-program trials. Supports moderate-certainty reductions in all-cause and cardiovascular mortality, stroke and nonfatal heart attack versus minimal intervention. Programs and cointerventions varied, so it does not isolate one ingredient or fixed menu. https://pubmed.ncbi.nlm.nih.gov/36990505/
- Ahmad et al., Women’s Health Study, JAMA Network Open (PMID 38819819). Cohort of 25,315 initially healthy women followed for a mean 24.7 years. Supports the 0.77 basic-model and 0.89 lifestyle-adjusted mortality hazard ratios. Diet was self-reported, the study was observational and 94.9% of participants were White. https://pubmed.ncbi.nlm.nih.gov/38819819/
- Nucci et al., 2026 Italian-guideline systematic review (PMID 41930792). Meta-analysis of 54 cohort studies with 1,833,267 participants, 346,034 deaths and two to 60 years of follow-up. Supports RR 0.96 per one-point adherence-score increase and moderate certainty; observational data cannot fully remove confounding. https://pubmed.ncbi.nlm.nih.gov/41930792/
- U.S. Centers for Disease Control and Prevention. Current public-health guidance says people who do not drink should not start and that even moderate alcohol can carry risk. This informs the wine advice; it does not test Mediterranean diets. About Moderate Alcohol Use
Photo credits
Images from Pexels.
- featured: Photo by cottonbro studio — original Pexels photo.
- inline-1: Photo by Lalada . — original Pexels photo.
- inline-2: Photo by Thirdman — original Pexels photo.
Leave a Reply